Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

OBJECTIVE—Hyperglycemia is a risk factor for microvascular complications and may increase the risk of cardiovascular disease in patients with type 2 diabetes. This study tested the LDL cholesterol–lowering agent colesevelam HCl (colesevelam) as a potential novel treatment for improving glycemic cont...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fonseca, Vivian A., Rosenstock, Julio, Wang, Antonia C., Truitt, Kenneth E., Jones, Michael R.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2008
Témata:
Clinical Care/Education/Nutrition/Psychosocial Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2494667/
https://ncbi.nlm.nih.gov/pubmed/18458145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-0283
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky